Novavax
NVAX
#5254
Rank
โ‚น157.86 B
Marketcap
โ‚น957.10
Share price
-3.72%
Change (1 day)
28.09%
Change (1 year)

Revenue for Novavax (NVAX)

Revenue in 2026 (TTM): โ‚น37.89 Billion

According to Novavax's latest financial reports the company's current revenue (TTM ) is โ‚น39.28 Billion. In 2025 the company made a revenue of โ‚น100.85 Billion an increase over the revenue in the year 2024 that were of โ‚น58.52 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Novavax from 1996 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น37.89 B-62.43%
2025 โ‚น100.85 B72.34%
2024 โ‚น58.52 B1.37%
2023 โ‚น57.72 B-49.93%
2022 โ‚น115.30 B35.14%
2021 โ‚น85.31 B145.3%
2020 โ‚น34.78 B2513.63%
2019 โ‚น1.33 B-44.49%
2018 โ‚น2.39 B20.44%
2017 โ‚น1.99 B90.8%
2016 โ‚น1.04 B-56.69%
2015 โ‚น2.40 B23.98%
2014 โ‚น1.94 B50.39%
2013 โ‚น1.29 B6.89%
2012 โ‚น1.20 B55.56%
2011 โ‚น0.77 B4955.33%
2010 โ‚น15.36 M1.92%
2009 โ‚น15.08 M-70.51%
2008 โ‚น51.14 M-0.14%
2007 โ‚น51.21 M-75.31%
2006 โ‚น0.20 B-37.61%
2005 โ‚น0.33 B-13.98%
2004 โ‚น0.38 B-27.98%
2003 โ‚น0.53 B-21.22%
2002 โ‚น0.68 B-41.34%
2001 โ‚น1.16 B905.27%
2000 โ‚น0.11 B121.43%
1999 โ‚น52.16 M75.27%
1998 โ‚น29.76 M26.23%
1997 โ‚น23.57 M118.64%
1996 โ‚น10.78 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Novartis
NVS
โ‚น5.383 T 13,600.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.047 T 15,292.85%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น5.826 T 14,730.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น4.210 T 10,615.88%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
โ‚น187.46 B 377.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚น15 M-99.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
โ‚น12.59 B-67.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
โ‚น89.31 B 127.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚น70.48 B 79.39%๐Ÿ‡บ๐Ÿ‡ธ USA